WeChat Mini Program
Old Version Features

P-084 Efficacy of Linvoseltamab in Prespecified High Risk Subgroups of Patients with Relapsed/Refractory Multiple Myeloma: Results from LINKER-MM1

Attaya Suvannasankha,Hans Lee,Naresh Bumma,Madhav V. Dhodapkar,Joshua Richter,James E. Hoffman,Mansi Shah,Suzanne Lentzsch,Jeffrey Zonder,Rachid Baz,Joseph J. Maly,Swathi Namburi,Ka Lung Wu,Matthew Pianko,Rebecca Silbermann,Chang-Ki Min,Marie-Christiane Vekemans,Markus Munder,Joaquín Martínez Lopez,Michelle DeVeaux

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views4
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined